On Monday, Nektar Therapeutics released a scathing public statement that accused its former partner, Eli Lilly, of miscalculating and sharing clinical trial results that underrepresented the...
On August 2, 2023, Altogen Biosystems announced and launched a new targeted reagent that can deliver biomolecules to the lungs, treating pulmonary diseases. According to the announcement, the drug has...
On July 28, 2023, the United States Food and Drug Administration (FDA) approved ReVive, an opioid reversal medication manufactured by Harm Reduction Therapeutics, a nonprofit pharmaceutical company. The concept of a nonprofit...
In a research letter published in JAMA Network Open on July 25, 2023, scientists evaluated data availability from pediatric clinical trials funded by the National Institutes of Health (NIH). According...
Addressing the top 10 most common myths about medicinal and recreational cannabis is critical to promote informed decision-making, reduce stigma, and foster evidence-based discussions, leading to safer use and better public policies....
Over the past few years, researchers have explored psychedelics, including lysergic acid diethylamide (LSD), ketamine, 3,4-methylenedioxymethamphetamine (MDMA), and more for treating mental health disorders. Among the many...
Throughout the past decade, psychedelics have become a primary area of interest for ongoing clinical research. Scientists have hypothesized multiple clinical use cases for these medications despite primarily being scheduled or illicit...
An analysis of 716 tap-water samples revealed that 45% of drinking water samples in the United States contained at least one tested per- and poly-fluoroalkyl substance (PFAS), also called forever...
On June 23, 2023, the United States Food and Drug Administration issued its first draft guidance on using psychedelic drugs in clinical trials. Marking a pivot in the clinical trial landscape, these...
Although drug-checking tools such as fentanyl test strips have been championed as critical harm-reduction tools in the opioid epidemic, additional data and research are required to assess their...
On May 31, 2023, JAMA Network Open published an article detailing the impacts of perfluoroalkyl and polyfluoroalkyl substance (PFAS) exposure on birth outcomes. Researchers determined that exposure to...
An open-label, randomized, noninferiority trial published in the New England Journal of Medicine revealed that ketamine and electroconvulsive therapy (ECT) were equally effective at managing...
While not a new concept, drug rationing across the United States has become an increasingly critical issue. In another tale about the dangers of high prescription drug costs, researchers published an...
Gaining popularity from celebrity endorsements and public speculation, Ozempic has become a staple weight loss drug in the United States. However, researchers speculate that the medication could...
After months of deliberation and review, the FDA has finally expanded its blood donor eligibility by adjusting its donation guidelines. Joining other developed nations, including the United Kingdom and...
A recent study published in the Annals of Neurology identified a link between sleeping pill use and lowered levels of Alzheimer's disease protein. Protein buildups and plaques identified in...
An analysis of the impact of the National Institutes of Health (NIH) funding requirements determined that they improve diversity in medical scientist training programs (MSTPs). The data revealed more...
Earlier this month, a study published in Obesity identified a link between weight gain and perfluorinated alkylate substances (PFAS), also known as forever chemicals, independent of dietary habits....
On April 24, 2023, researchers published the results of a cohort study analyzing the effect of neutralizing monoclonal antibodies (nMABs) on patients with COVID-19, noting significantly improved...
Insufficient sleep has detrimental effects on vaccine efficacy. A recent meta-analysis published in Current Biology determined that less than six hours of sleep per night resulted in a reduced antibody...
